Structure of Tolterodine tartrate
CAS No.: 124937-52-6
*Storage: {[sel_prStorage]}
*Shipping: {[sel_prShipping]}
The BI-3802 was designed by Boehringer Ingelheim and could be obtained free of charge through the Boehringer Ingelheim open innovation portal opnMe.com, associated with its negative control.
Tolterodine tartrate is a competitive mAchR antagonist possessing both antimuscarinic and antispasmodic properties.
Synonyms: PNU-200583E; Kabi-2234; Tolterodine (tartrate)
4.5
*For Research Use Only !
Change View
Size | Price | VIP Price | US Stock |
Global Stock |
In Stock | ||
{[ item.pr_size ]} |
Inquiry
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.discount_usd) ]} {[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} |
Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]} | Inquiry {[ item.pr_usastock ]} In Stock Inquiry - | {[ item.pr_chinastock ]} {[ item.pr_remark ]} In Stock 1-2 weeks - Inquiry - | Login | - + | Inquiry |
Please Login or Create an Account to: See VIP prices and availability
US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days
1-2weeks
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd,1,item.mem_rate,item.pr_is_large_size_no_price, item.pr_usd) ]}
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
In Stock
- +
Please Login or Create an Account to: See VIP prices and availability
US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
CAS No. : | 124937-52-6 |
Formula : | C26H37NO7 |
M.W : | 475.57 |
SMILES Code : | OC1=CC=C(C)C=C1[C@@H](C2=CC=CC=C2)CCN(C(C)C)C(C)C.O=C(O)[C@H](O)[C@@H](O)C(O)=O |
Synonyms : |
PNU-200583E; Kabi-2234; Tolterodine (tartrate)
|
MDL No. : | MFCD07771985 |
InChI Key : | TWHNMSJGYKMTRB-KXYUELECSA-N |
Pubchem ID : | 443878 |
GHS Pictogram: |
![]() |
Signal Word: | Warning |
Hazard Statements: | H315-H319-H335 |
Precautionary Statements: | P261-P305+P351+P338 |
Clinical Trial:
NCT Number | Conditions | Phases | Recruitment | Completion Date | Locations |
NCT03662893 | Overactive Bladder | Not Applicable | Completed | - | Turkey ... More >> Ankara Training and Research Hospital Ankara, Turkey, 06340 Less << |
NCT00780832 | Overactive Bladder | Not Applicable | Terminated(Insufficient elligi... More >>ble patients available in a reasonable time frame.) Less << | - | Canada, Nova Scotia ... More >> IWK Health Centre Halifax, Nova Scotia, Canada, B3K 6R8 Less << |
NCT01661621 | - | Completed | - | - | |
NCT01661621 | Bladder Outlet Obstruction | Phase 4 | Completed | - | Taiwan ... More >> Buddhist Tzu Chi General Hospital Hualien, Taiwan, 970 Less << |
NCT01210859 | - | Withdrawn | December 2012 | - | |
NCT01050114 | Overactive Bladder | Phase 3 | Unknown | July 2018 | United States, Texas ... More >> Baylor College of Medicine Recruiting Houston, Texas, United States, 77030 Contact: Sebrina Tello 713-798-8106 stello@bcm.edu TIRR-Memorial Hermann Not yet recruiting Houston, Texas, United States, 77030 Contact: Sebrina Tello 713-798-8106 stello@bcm.edu Sub-Investigator: John E. Bertini, Jr., MD Less << |
NCT00547378 | - | Completed | - | - | |
NCT00366002 | Overactive Bladder (OAB) | Phase 4 | Completed | - | - |
NCT00220363 | Overactive Bladder Syndrome | Phase 3 | Completed | - | Germany ... More >> Schwarz Monheim, Germany Less << |
NCT00547378 | Urinary Incontinence, Urgency-... More >>frequency Overactive Bladder Less << | Phase 4 | Completed | - | - |
NCT02160158 | Healthy | Phase 1 | Completed | - | Belgium ... More >> Pfizer Clinical Research Unit Brussels, Belgium, B-1070 Less << |
NCT03572231 | - | Recruiting | December 2019 | Korea, Republic of ... More >> Site KR410008 Recruiting Daejeon, Korea, Republic of Site KR410009 Recruiting Incheon, Korea, Republic of Site KR410001 Recruiting Seoul, Korea, Republic of Site KR410003 Recruiting Seoul, Korea, Republic of Site KR410006 Recruiting Seoul, Korea, Republic of Taiwan Site TW158001 Recruiting Hualien City, Taiwan Less << | |
NCT00313924 | Overactive Bladder | Phase 4 | Unknown | - | Israel ... More >> Rambam Healthcare Center Recruiting Haifa, Israel, 31096 Sub-Investigator: IRENA GERTMAN, MD Less << |
NCT00507169 | Overactive Bladder (OAB) | Phase 2 | Completed | - | - |
NCT00337090 | Overactive Bladder | Phase 2 | Completed | - | - |
NCT00425100 | Overactive Bladder | Phase 3 | Completed | - | - |
NCT01011036 | Pain | Phase 3 | Completed | - | Switzerland ... More >> Dep of Anesthesiology and Pain Therapy, University Hospital Bern Bern, Switzerland, 3010 Less << |
NCT02294396 | Overactive Bladder (OAB) | Phase 4 | Completed | - | Japan ... More >> Chubu, Japan Chugoku, Japan Hokkaido, Japan Kansai, Japan Kantou, Japan Kyushu, Japan Tohoku, Japan Less << |
NCT00876421 | Overactive Bladder | Phase 2 | Completed | - | - |
NCT02256956 | Chronic Pain | Phase 4 | Recruiting | May 2018 | Switzerland ... More >> Dep. of Anesthesiology, Bern University Hospital Recruiting Bern, Switzerland, 3010 Contact: Pascal H Vuilleumier, MD +41 31 632 17 09 pascal.vuilleumier@insel.ch Contact: Jürg Schliessbach, MD juerg.schliessbach@insel.ch Principal Investigator: Pascal H Vuilleumier, MD Sub-Investigator: Jürg Schliessbach, MD Sub-Investigator: Frank Stüber, Prof. Sub-Investigator: Ulrike Stamer, Prof. Less << |
NCT01043666 | Urinary Bladder, Overactive | Phase 3 | Completed | - | China ... More >> Beijing, China Dalian, China Fuzhou, China Guangzhou, China Hangzhou, China Hubei, China Hunan, China Jiangsu, China Liaoning, China Nanjing, China Shanghai, China India Ahmedabad, India Gurgaon, India Jaipur, India Lucknow, India New Delhi, India Pune, India Korea, Republic of Busan, Korea, Republic of Chungcheong Namdo, Korea, Republic of Daegu, Korea, Republic of Daejeon, Korea, Republic of Gwangju, Korea, Republic of Gyeonggi, Korea, Republic of Incheon, Korea, Republic of Jeollabuk, Korea, Republic of Jeollanam, Korea, Republic of Kyonggi, Korea, Republic of Seoul, Korea, Republic of Taiwan Chia-Yi, Taiwan Hualien, Taiwan Kaohsiung, Taiwan Taichung, Taiwan Tainan, Taiwan Taipei, Taiwan Taoyuan, Taiwan Less << |
NCT02256943 | Chronic Pain | Phase 4 | Recruiting | May 2018 | Switzerland ... More >> Dep. of Anesthesiology, Bern University Hospital Recruiting Bern, Switzerland, 3010 Contact: Pascal H Vuilleumier, MD +41 31 632 17 09 pascal.vuilleumier@insel.ch Contact: Jürg Schliessbach, MD juerg.schliessbach@insel.ch Principal Investigator: Pascal H Vuilleumier, MD Sub-Investigator: Jürg Schliessbach, MD Sub-Investigator: Frank Stüber, Prof. Sub-Investigator: Ulrike Stamer, Prof. Less << |
NCT00174798 | Overactive Bladder | Phase 2 | Completed | - | - |
NCT01004315 | Overactive Bladder | Phase 3 | Completed | - | Japan ... More >> Japan Hokkaido,Tohoku,Kanto,Chubu,Kansai,Shikoku,Kyushu, Japan Less << |
NCT03280316 | Spinal Vascular Disorder Nos ... More >> Overactive Bladder Less << | Not Applicable | Not yet recruiting | December 2019 | - |
NCT00498888 | Urge Urinary Incontinence | Not Applicable | Completed | - | Israel ... More >> Rehabilitation and Physical Therapy Center, Maccabi Healthcare Services Rishon Le Zion, Israel, 75429 Less << |
NCT01179828 | Low Back Pain | Phase 3 | Completed | - | Switzerland ... More >> Andreas Siegenthaler Dep. of Anesthesiolgy and Pain therapy, Bern University Hospital, Switzerland, 3010 Bern Less << |
NCT01291316 | Neuropathic Pain | Phase 1 Phase 2 | Completed | - | Switzerland ... More >> University Hospitals Geneva, Switzerland, 1211 Less << |
NCT00553657 | Overactive Bladder | Phase 1 | Completed | - | Australia, New South Wales ... More >> GSK Investigational Site Randwick, Sydney, New South Wales, Australia, 2031 Less << |
NCT01829425 | Urinary Incontinence, Urge | Not Applicable | Completed | - | United States, New Mexico ... More >> University of New Mexico Health Science Center Albuquerque, New Mexico, United States, 87131 Less << |
NCT01824420 | Overactive Bladder | Phase 4 | Completed | - | Taiwan ... More >> Buddhist Tzu Chi General Hospital Hualien, Taiwan, 970 Less << |
NCT01512004 | Overactive Bladder | Phase 3 | Completed | - | China ... More >> Beijing Chaoyang Hospital Beijing, China Less << |
NCT00425100 | - | Completed | - | - | |
NCT03602508 | - | Active, not recruiting | February 2019 | Australia ... More >> Site AU10000 Sydney, Australia Korea, Republic of Site KR82001 Seoul, Korea, Republic of Less << | |
NCT00189800 | Overactive Bladder | Phase 3 | Completed | - | Korea, Republic of ... More >> Anyang, Korea, Republic of Bucheon, Korea, Republic of Busan, Korea, Republic of Cheonan, Korea, Republic of Daegu, Korea, Republic of Daejeon, Korea, Republic of Gwangju, Korea, Republic of Incheon, Korea, Republic of Seoul, Korea, Republic of Suwon, Korea, Republic of Less << |
NCT00448175 | - | Completed | - | - | |
NCT01566760 | Urinary Bladder, Overactive | Phase 1 | Completed | - | Singapore ... More >> Pfizer Investigational Site Singapore, Singapore, 188770 Less << |
NCT00689104 | - | Completed | - | - | |
NCT00648310 | Overactive Bladder | Phase 2 Phase 3 | Completed | - | Italy ... More >> Department of Gynecology and Obstetrics - Università dell'Insubria Varese, Italy, 21100 Less << |
NCT00689104 | Urinary Bladder, Overactive | Phase 3 | Completed | - | - |
NCT00090584 | Urinary Incontinence (UI) | Not Applicable | Completed | - | United States, Alabama ... More >> University of Alabama Birmingham, Alabama, United States, 35233 United States, California University of California San Diego, California, United States, 92103 United States, Illinois Loyola University Medical Center Maywood, Illinois, United States, 60153 United States, Maryland University of Maryland Baltimore, Maryland, United States, 21201 United States, Michigan Oakwood Hospital and Medical Center Royal Oak, Michigan, United States, 48123 United States, Pennsylvania University of Pittsburgh Pittsburgh, Pennsylvania, United States, 15213 United States, Texas University of Texas Southwestern Dallas, Texas, United States, 75390 University of Texas Health Sciences Center San Antonio, Texas, United States, 78229 United States, Utah University of Utah Salt Lake City, Utah, United States, 84132 Less << |
NCT00090584 | - | Completed | - | - | |
NCT01500382 | Overactive Bladder ... More >> Overactive Urinary Bladder Less << | Phase 1 | Terminated(This study was term... More >>inated early due to insufficient recruitment.) Less << | - | - |
NCT00688688 | Urinary Bladder, Overactive | Phase 3 | Completed | - | - |
NCT00852696 | Overactive Bladder | Phase 4 | Completed | - | United States, Florida ... More >> Cleveland Clinic Florida Weston, Florida, United States, 33331 Less << |
NCT00448175 | Overactive Bladder | Phase 4 | Completed | - | United States, Minnesota ... More >> Uroplasty, Inc Minnetonka, Minnesota, United States, 55343 Less << |
NCT01282840 | Lower Urinary Tract Symptoms | Not Applicable | Unknown | December 2017 | Taiwan ... More >> Far Eastern Memorial Hospital Recruiting Pan-Chiao, Taiwan Contact: Hsiao Sheng Mou, MD +886-2-89667000 ext 124 smhsiao2@gmail.com Less << |
NCT01500382 | - | Terminated(This study was term... More >>inated early due to insufficient recruitment.) Less << | - | - | |
NCT00688688 | - | Completed | - | - | |
NCT00143377 | Urinary Incontinence | Phase 4 | Completed | - | - |
NCT00966004 | Urinary Bladder, Overactive | Phase 3 | Completed | - | Japan ... More >> Chubu, Japan Kantou, Japan Kinki, Japan Kyushu, Japan Less << |
NCT02485067 | Overactive Bladder | Phase 3 | Completed | - | Korea, Republic of ... More >> Inje University Busan Paik Hospital Busan, Korea, Republic of Dankook University Hospital Cheonan, Korea, Republic of Chonnam National University Hospital Gwangju, Korea, Republic of Pusan National University Hospital Pusan, Korea, Republic of Bundang Cha Medical center Seongnam, Korea, Republic of Ajou University Medical Center Seoul, Korea, Republic of Asan Medical Center Seoul, Korea, Republic of Cheil General Hospital Seoul, Korea, Republic of Gachon University Gil Medical Center Seoul, Korea, Republic of Konkuk University Medical Center Seoul, Korea, Republic of Korea University Anam Hospital Seoul, Korea, Republic of Samsung Medical Center Seoul, Korea, Republic of Seoul National University Hospital Seoul, Korea, Republic of Severance Hospital Seoul, Korea, Republic of The Catholic University of Korea, Bucheon ST. Mary's Hospital Seoul, Korea, Republic of The Catholic University of Korea, Seoul ST. Mary's Hospital Seoul, Korea, Republic of Less << |
NCT01175382 | Overactive Bladder ... More >> Lower Urinary Tract Symptoms Less << | Phase 2 Phase 3 | Completed | - | United States, Alabama ... More >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35294 United States, Georgia Emory University Atlanta, Georgia, United States, 30033 United States, Texas University of Texas Health Science Center San Antonio San Antonio, Texas, United States, 78229 Less << |
NCT00481728 | Overactive Bladder | Phase 1 | Completed | - | Switzerland ... More >> Pfizer Investigational Site Zurich, Switzerland, CH- 8008 Less << |
NCT00836381 | Overactive Bladder | Phase 4 | Completed | - | Korea, Republic of ... More >> Samsung Medical Center Seoul, Korea, Republic of Less << |
NCT01175382 | - | Completed | - | - | |
NCT01089751 | Overactive Bladder | Phase 4 | Completed | - | United States, California ... More >> La Mesa, California, United States Less << |
NCT00564226 | Overactive Bladder | Phase 2 | Completed | - | United States, New Jersey ... More >> Sanofi-Aventis Aministrative Office Bridgewater, New Jersey, United States, 08807 Canada, Quebec Sanofi-Aventis Administrative Office Laval, Quebec, Canada Czech Republic Sanofi-Aventis Administrative Office Praha, Czech Republic France Sanofi-Aventis Administrative Office Paris, France Germany Sanofi-Aventis Administrative Office Berlin, Germany Netherlands Sanofi-Aventis Administrative Office Gouda, Netherlands Portugal Sanofi-Aventis Administrative Office Porto Salvo, Portugal Less << |
NCT01089751 | - | Completed | - | - | |
NCT01604928 | Urinary Bladder, Overactive | Phase 2 | Completed | - | Belgium ... More >> Site: 12 Brussels, Belgium, 1090 Site: 13 Edegem, Belgium, 2650 Site: 11 Gent, Belgium, 9000 Site: 10 Leuven, Belgium, 3000 Czech Republic Site: 25 Melnik, Czech Republic, 276 01 Site: 22 Prague, Czech Republic, 128 08 Site: 24 Prague, Czech Republic, 140 59 Site: 20 Prague, Czech Republic, 180 81 Site: 21 Usti nad Labem, Czech Republic, 40001 Site: 23 Usti nad Labem, Czech Republic, 401 13 Germany Site: 32 Bad Ems, Germany, 56130 Site: 30 Emmendingen, Germany, 79312 Site: 35 Frankfurt, Germany, 60326 Site: 34 Hagenow, Germany, 19230 Site: 33 Hamburg, Germany, 20253 Site: 36 Koblenz, Germany, 56068 Site: 31 Trier, Germany, 54290 Spain Site: 42 Alzira-Valencia, Spain, 46600 Site: 40 Madrid, Spain, 28046 Site: 43 Miranda de Ebro, Spain, 09200 Sweden Site: 55 Gotenburg, Sweden, 413 45 Site: 53 Linkoping, Sweden, 582 24 Site: 50 Lund, Sweden, 221 85 Site: 51 Stockholm, Sweden, 141 86 Site: 52 Uppsala, Sweden, 751 85 United Kingdom Site: 64 Bimingham, United Kingdom, B15 2TG Site: 62 London, United Kingdom, N19 5LW Site: 63 London, United Kingdom, W1P 7PN Site: 60 Sheffield, United Kingdom, S10 2JF Site: 61 Swansea, United Kingdom, SA6 6NL Less << |
NCT01356355 | Ureteral Stent Discomfort | Phase 2 | Completed | - | India ... More >> AMAI Charitable Trust's ACE Hospital Pune Pune, Maharashtra, India, 411004 Less << |
NCT01530243 | Disorder of Urinary Stent | Phase 2 Phase 3 | Completed | - | Iran, Islamic Republic of ... More >> Imam Khomeini Hospital Urmia, Azerbaijan-gharbi, Iran, Islamic Republic of Less << |
NCT01302054 | - | Completed | - | - | |
NCT01530243 | - | Completed | - | - | |
NCT03492281 | Overactive Bladder | Phase 3 | Active, not recruiting | March 31, 2019 | - |
NCT03583372 | Overactive Bladder | Phase 3 | Active, not recruiting | January 5, 2020 | - |
NCT00523068 | Mixed Urinary Incontinence ... More >> Urinary Incontinence, Stress Urinary Incontinence, Urge Less << | Phase 4 | Unknown | January 2010 | United Kingdom ... More >> Demetri C Panayi Not yet recruiting London, United Kingdom, sw18 4qr Contact: Demetri C Panayi, BSc MRCOG 02078861016 d.panayi@imperial.ac.uk Less << |
NCT00147654 | Urinary Incontinence | Phase 4 | Completed | - | - |
NCT00368706 | Urinary Bladder, Overactive | Phase 3 | Completed | - | China ... More >> Beijing, China, 100000 Chong Qing, China, 404000 Hang Zhou, China, 310000 Shanghai, China, 200000 Less << |
NCT01302054 | Urinary Bladder, Overactive | Phase 4 | Completed | - | - |
NCT00230789 | Urinary Incontinence | Phase 4 | Completed | - | - |
NCT00282932 | Overactive Bladder (OAB) | Phase 4 | Completed | - | - |
NCT00454740 | Urinary Bladder, Overactive | Phase 3 | Completed | - | - |
NCT00137397 | Urinary Incontinence | Phase 4 | Completed | - | United Kingdom ... More >> Pfizer Investigational Site Blackburn, Lancashire, United Kingdom, BB2 3HH Pfizer Investigational Site Harrow, Middx, United Kingdom, HA1 3UJ Pfizer Investigational Site Oxford, Oxfordshire, United Kingdom, OX3 9DU Pfizer Investigational Site Livingston, West Lothian, United Kingdom, EH54 6PP Pfizer Investigational Site Basingstoke, United Kingdom, RG24 9NA Pfizer Investigational Site Birmingham, United Kingdom, B15 2TG Pfizer Investigational Site Cambs, United Kingdom, PE18 8NT Pfizer Investigational Site London, United Kingdom, SE5 9RS Pfizer Investigational Site London, United Kingdom, W2 2YP Pfizer Investigational Site Northampton, United Kingdom, NN1 5BD Pfizer Investigational Site Pl6 8Dh, United Kingdom Less << |
NCT00611026 | Overactive Bladder | Phase 3 | Completed | - | - |
NCT01314872 | Urinary Bladder, Overactive | Phase 2 | Completed | - | - |
NCT00439192 | Overactive Bladder ... More >> Urinary Incontinence Less << | Phase 2 | Terminated(side effect profile... More >> did not match expectations) Less << | - | Germany ... More >> Private Gynecological Practice Alzey, Germany, 55232 Private Urologic Practice Berlin, Germany, 12247 Private Urologic Practice Berlin, Germany, 13057 Private Urologic Practice Borken, Germany, 46325 Private Urologic Practice Duisburg, Germany, 47051 Private Urologic Practice Duisburg, Germany, 47179 Private Urologic Practice Essen, Germany, 45355 Private Urologic Practice Greifswald, Germany, 17493 Private Urologic Practice Hamburg, Germany, 20097 Private Urologic Practice Hamburg, Germany, 20249 Private Urologic Practice Homburg Saar, Germany, 66424 Private Urologic Practice Kleinblittersdorf, Germany, 66271 Private Urologic Practice Marburg, Germany, 35037 Private Urologic Practice Muelheim, Germany, 45468 Private Urologic Practice Munich, Germany, 81925 Private Urologic Practice Mühlacker, Germany, 75417 Private Urologic Practice Oberursel, Germany, 61440 Private Urologic Practice Stuttgart, Germany, 70372 Poland NZOZ Centrum Medyczne dr n. med. Artur Racewicz Bialystok, Poland, 15-337 Urovita Sp z o.o. Chorzow, Poland, 41-500 Invicta Sp z o.o. Gdansk, Poland, 80-850 Szpital Specjalistyczny w Koscierzynie, Dep. Oddzial Urologii Koscierzyna, Poland, 83-400 NZOZ Specjalista Sp. z o.o. Kutno, Poland, 99-300 NZOZ Nasz Lekarz, Praktyka Grupowa Lekarzy Rodzinnych z Przychodnia Specjalistyczna Torun, Poland, 87-100 Szpital Kliniczny - Centrum Leczenia Obrazen "Dzieciatka Jezus" Warszawa, Poland, 02-005 Centrum Leczenia Chorob Cywilizacyjnych Andrzej Opadczuk Warszawa, Poland, 02-777 EMC Instytut Medyczny S.A., EuroMediCare, Szpital Specjalistyczny z Przychodnia Wroclaw, Poland, 54-144 Sweden University Hospital Linköping Linköping, Sweden, 581 85 Karolinska University Hospital Huddinge Stockholm, Sweden, 141 86 Danderyds Hospital Stockholm, Sweden, 182 88 University Hospital Uppsala Uppsala, Sweden, 751 85 Less << |
NCT00611026 | - | Completed | - | - | |
NCT00293839 | Urinary Incontinence | Phase 3 | Completed | - | - |
NCT00922506 | Overactive Bladder ... More >> Benign Prostatic Hyperplasia Less << | Phase 4 | Unknown | November 2015 | Korea, Republic of ... More >> Samsung Medical Center Recruiting Seoul, Korea, Republic of, 135-710 Contact: Kyu-Sung Lee, Ph.D 82-2-3410-3554 ksleedr@skku.edu Principal Investigator: Kyu-Sung Lee, Ph.D Less << |
NCT01314872 | - | Completed | - | - | |
NCT02599311 | Pelvic Organ Prolapse | Phase 3 | Recruiting | October 2020 | China, Beijing ... More >> Peking University People's Hospital Recruiting Beijing, Beijing, China, 100044 Contact: Tingting Cao, resident 861088324354 sxlctt2015@126.com Less << |
NCT02877901 | Nocturnal Incontinence | Phase 2 Phase 3 | Completed | - | - |
NCT00143481 | Urinary Incontinence | Phase 4 | Completed | - | - |
NCT01741454 | Ureteral Obstruction | Phase 4 | Completed | - | United States, Wisconsin ... More >> University of Wisconsin Madison, Wisconsin, United States, 53792 Less << |
NCT01729819 | Overactive Bladder | Phase 2 | Completed | - | - |
NCT01521767 | Urinary Bladder, Overactive | Phase 1 | Completed | - | Singapore ... More >> Pfizer Investigational Site Singapore, Singapore, 188770 Less << |
NCT00444925 | Overactive Bladder | Phase 3 | Completed | - | - |
NCT00746681 | Overactive Bladder | Phase 2 | Completed | - | Czech Republic ... More >> Pfizer Investigational Site Hradec Kralove, Czech Republic, 500 05 Pfizer Investigational Site Praha 1, Czech Republic, 110 00 Pfizer Investigational Site Praha 3, Czech Republic, 130 00 Pfizer Investigational Site Praha 4 - Krc, Czech Republic, 140 59 Pfizer Investigational Site Usti Nad Labem, Czech Republic, 401 13 Lithuania Pfizer Investigational Site Kaunas, Lithuania, LT-47144 Pfizer Investigational Site Kaunas, Lithuania, LT-50009 Pfizer Investigational Site Vilnius, Lithuania, LT-01118 Pfizer Investigational Site Vilnius, Lithuania, LT-08661 Norway Pfizer Investigational Site Haugesund, Norway, 5507 Pfizer Investigational Site Moelv, Norway, N-2390 Pfizer Investigational Site Trondheim, Norway, 7006 Slovakia Pfizer Investigational Site Bratislava, Slovakia, 901 01 Pfizer Investigational Site Kosice, Slovakia, 040 11 Pfizer Investigational Site Martin, Slovakia Pfizer Investigational Site Skalica, Slovakia, 909 82 Sweden Pfizer Investigational Site Lulea, Sweden, 97180 Pfizer Investigational Site Norrkoping, Sweden, 601 82 Pfizer Investigational Site Stockholm, Sweden, 141 86 United Kingdom Pfizer Investigational Site Dundee, Tayside, United Kingdom, DD1 9SY Pfizer Investigational Site Bristol, United Kingdom, BS10 5NB Pfizer Investigational Site Dundee, United Kingdom, DD1 9SY Pfizer Investigational Site Plymouth, United Kingdom, PL6 8DH Less << |
NCT00332137 | Health | Phase 2 | Completed | - | United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less << |
NCT00802373 | Urinary Bladder, Overactive | Phase 3 | Completed | - | - |
NCT00444925 | - | Completed | - | - | |
NCT01503580 | Antimuscarinic Drug | Not Applicable | Completed | - | Taiwan ... More >> Department of Gynecology,National Taiwan University Hospital Taipei, Taiwan Less << |
NCT01036035 | Incontinence | Phase 1 | Completed | - | - |
NCT00646880 | Urinary Bladder, Overactive | Phase 3 | Completed | - | Korea, Republic of ... More >> Pfizer Investigational Site Seoul, Korea, Republic of, 110-744 Less << |
NCT01729819 | - | Completed | - | - | |
NCT00730535 | Overactive Bladder | Phase 4 | Completed | - | Korea, Republic of ... More >> Samsung Medical Center 50 Ilwon-Dong, Kangnam-Gu, Seoul, Korea, Republic of, 135-710 Holy Family Hospital, The Catholic University of Korea Kyonggi-do, Korea, Republic of Asan Medical Center, Ulsan College of Medicine Seoul, Korea, Republic of Seoul National University Hospital Seoul, Korea, Republic of Less << |
NCT00411437 | Memory Cognit... More >>ion Less << | Phase 4 | Completed | - | United States, Arizona ... More >> Pfizer Investigational Site Tucson, Arizona, United States, 85741 United States, Florida Pfizer Investigational Site Brooksville, Florida, United States, 34613 Pfizer Investigational Site DeLand, Florida, United States, 32720 Pfizer Investigational Site Naples, Florida, United States, 34102 Pfizer Investigational Site Ocala, Florida, United States, 34471 Pfizer Investigational Site Ocala, Florida, United States, 34474 Pfizer Investigational Site St. Petersburg, Florida, United States, 33709 Pfizer Investigational Site Tampa, Florida, United States, 33606 Pfizer Investigational Site West Palm Beach, Florida, United States, 33407 Less << |
NCT00913315 | Prostatitis | Not Applicable | Unknown | January 2010 | China, Chongqing ... More >> Department of Urology, the First Affiliated Hospital of Chongqing Medical University Not yet recruiting Chongqing, Chongqing, China, 400016 Contact: Xiaohou Wu, MD 86-2389011122 93404840@qq.com Less << |
NCT01302938 | Overactive Bladder | Phase 4 | Terminated(Stop date for rando... More >>mization 31/5/2012. Recruitment terminated due to lack of recruitment. No new safety issues were identified.) Less << | - | United States, California ... More >> Mytrus, Inc. San Francisco, California, United States, 94104 University of California San Francisco San Francisco, California, United States, 94121 Less << |
NCT00139724 | Urinary Incontinence | Phase 3 | Completed | - | China, Beijing ... More >> Pfizer Investigational Site Beijing, Beijing, China, 100020 Pfizer Investigational Site Beijing, Beijing, China, 100034 China, Zhejiang Pfizer Investigational Site Huangzhou, Zhejiang, China, 310003 China Pfizer Investigational Site Beijing, China, 100034 Pfizer Investigational Site Chongqing, China Pfizer Investigational Site Shanghai, China, 200040 Pfizer Investigational Site Shanghai, China, 200127 Less << |
NCT02436889 | Urge Incontinence ... More >> Urinary Incontinence, Urge Less << | Phase 4 | Completed | - | United States, California ... More >> University of California, San Francisco San Francisco, California, United States, 94115 Less << |
NCT00465894 | Overactive Bladder | Not Applicable | Completed | - | - |
NCT00413790 | Healthy | Phase 4 | Completed | - | United States, Arizona ... More >> Investigative Site Scottsdale, Arizona, United States, 85251 Investigative Site Tempe, Arizona, United States, 85282 United States, California Investigative Site San Diego, California, United States, 92103 United States, Florida Investigative Site Jacksonville, Florida, United States, 32216 Investigative Site Jupiter, Florida, United States, 33458 United States, Kansas Investigative Site Overland Park, Kansas, United States, 66215 United States, Kentucky Investigative Site Madisonville, Kentucky, United States, 42431 United States, Massachusetts Investigative Site Wellesley Hills, Massachusetts, United States, 02481 United States, New Jersey Investigative Site Hackensack, New Jersey, United States, 07601 United States, New York Investigative Site Buffalo, New York, United States, 14202 United States, Texas Investigative Site Austin, Texas, United States, 78752 Investigative Site Dallas, Texas, United States, 75235 Less << |
NCT03575702 | Overactive Bladder | Phase 3 | Completed | - | Russian Federation ... More >> Family polyclinic №4, LLC Korolev, Russian Federation A.I. Evdokimov Moscow State University of Medicine and Dentistry, Municipal Clinical Hospital named after Spasokukotskiy S.I Moscow, Russian Federation N.I. Pirogov Russian National Research University Moscow, Russian Federation National Medical Radiological Center Moscow, Russian Federation National N.I. Pirogov Medical and Surgical Center Moscow, Russian Federation Rostov State Medical University Rostov-on-Don, Russian Federation All-Russian A.M. Nikiforov Center for Emergency and Radiation Medicine Saint Petersburg, Russian Federation Baltic Medicine LLC Saint Petersburg, Russian Federation I.P. Pavlov First St. Petersburg State Medical University Saint Petersburg, Russian Federation OrKli Hospital, LLC Saint Petersburg, Russian Federation St. Petersburg State-Funded Healthcare Institution St. Luka Clinical Hospital Saint Petersburg, Russian Federation Less << |
NCT00465894 | - | Completed | - | - | |
NCT01181505 | Genotype Guided(HNF4a) ... More >> Healthy Subjects Less << | Phase 1 | Completed | - | - |
NCT00795509 | Urinary Bladder, Overactive | COMPLETED | 2025-03-11 | - | |
NCT00795509 | Urinary Bladder, Overactive | COMPLETED | 2025-03-11 | - | |
NCT00703703 | Healthy | Phase 1 | Completed | - | United States, Arizona ... More >> Investigative Site Phoenix, Arizona, United States Investigative Site Tempe, Arizona, United States United States, Arkansas Investigative Site Little Rock, Arkansas, United States United States, California Investigative Site San Diego, California, United States United States, District of Columbia Investigative Site Washington, District of Columbia, United States United States, Florida Investigative Site Fort Myers, Florida, United States Investigative Site Jacksonville, Florida, United States Investigative Site Jupiter, Florida, United States Investigative Site Miami, Florida, United States Investigative Site Orlando, Florida, United States United States, Kansas Investigative Site Overland Park, Kansas, United States Investigative Site Topeka, Kansas, United States United States, Maryland Investigative Site Riverdale, Maryland, United States United States, Massachusetts Investigative Site Wellesley Hills, Massachusetts, United States United States, Missouri Investigative Site Springfield, Missouri, United States United States, New Jersey Investigative Site Hackensack, New Jersey, United States United States, North Carolina Investigative Site Burlington, North Carolina, United States Investigative Site Greensboro, North Carolina, United States United States, Oklahoma Investigative Site Oklahoma City, Oklahoma, United States United States, Tennessee Investigative Site Knoxville, Tennessee, United States United States, West Virginia Investigative Site Morgantown, West Virginia, United States Less << |
NCT02138747 | - | Completed | - | - | |
NCT01302938 | - | Terminated(Stop date for rando... More >>mization 31/5/2012. Recruitment terminated due to lack of recruitment. No new safety issues were identified.) Less << | - | - | |
NCT02138747 | Overactive Bladder (OAB) | Phase 4 | Completed | - | - |
NCT00323635 | Urinary Incontinence | Phase 4 | Terminated(New department chai... More >>rman instructed PI to discontinue study.) Less << | - | United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Brigham & Women's Hospital Boston, Massachusetts, United States, 02120 Less << |
NCT00323635 | - | Terminated(New department chai... More >>rman instructed PI to discontinue study.) Less << | - | - | |
NCT01964183 | Pharmacokinetics of Mirabegron... More >> and Tolterodine Healthy Less << | Phase 4 | Completed | - | Japan ... More >> Kanto, Japan Less << |
NCT00939120 | - | Completed | - | - | |
NCT00939120 | Benign Prostatic Hyperplasia (... More >>BPH) Less << | Phase 4 | Completed | - | United States, Indiana ... More >> Deaconess Clinic Gateway Health Center Newburgh, Indiana, United States, 47630 Less << |
NCT01488578 | Overactive Bladder | COMPLETED | 2025-03-11 | - | |
NCT02723279 | Urgency-frequency Syndrome | Not Applicable | Completed | - | China ... More >> Shanghai research institute of acupuncture and meridian Shanghai, China, 200030 Less << |
NCT00768521 | - | Completed | - | - | |
NCT00645281 | Urinary Bladder, Overactive | Phase 4 | Completed | - | - |
NCT01488578 | Overactive Bladder | COMPLETED | 2025-03-11 | - | |
NCT00768521 | Overactive Bladder | Phase 1 | Completed | - | - |
Bio Calculators | ||||
Preparing Stock Solutions | ![]() |
1mg | 5mg | 10mg |
1 mM 5 mM 10 mM |
2.10mL 0.42mL 0.21mL |
10.51mL 2.10mL 1.05mL |
21.03mL 4.21mL 2.10mL |
|
Dissolving Methods |
in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day; The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound. Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:
|